Overview

Associate Professor Bonny is Interim Deputy Director at the Macquarie University Centre for the Health Economy (MUCHE) (2023 -). Previously she was an Associate Professor and Senior Research fellow at MUCHE (2015-2022), and a Research Fellow at the Centre for Health Economics, Research and Evaluation at the University of Technology Sydney (UTS) (2009-2015). She has also worked at AstraZeneca in the United Kingdom as a senior health economist, Access Economics in Canberra as a senior economist, and the Social Policy Evaluation and Research Centre at the Australian National University as an Assistant researcher.

Experience

A/Prof Parkinson’s expertise is in the field of health economics, especially regarding pharmaceutical policy, economic evaluation methodology, cancer, hearing, and precision medicine. She has conducted or supervised economic evaluations of many healthcare interventions, including medicines (e.g. trastuzumab, triptans, the oral contraceptive pill), diagnostics (e.g. prostate specific membrane antigen positron emissions tomography/computed tomography (PSMA PET/CT), screening for lynch syndrome and hearing loss), medical devices (e.g. Cochlear implants), and digital technologies (e.g. BRECONDA and SoundScouts). This has included the application of economic modelling and within-trial analysis, analysis of linked healthcare administrative data using advanced econometric analysis, qualitative research using focus groups and interviews, and health preference research. She currently co-leads the health technology assessment stream, and has been involved in over 70 evaluations of submissions to the Pharmaceutical Benefits Advisory Committee (PBAC), 6 evaluations of submissions to the Medical Services Advisory Committee (MSAC) and the National Diabetes Subsidy Scheme (NDSS) since 2009. To date, she has been the recipient of career research funding of over $33.5 million spread over 29 grants. She has over 50 peer-reviewed journal articles in high quality journals including Health Economics (ABDC A*), Pharmacoeconomics (A), European Journal of Health Economics (A) and Economic Modelling (A).

She's has been awarded the Australian Health Economics Society Rising Star award (2022), the Macquarie University Academic Staff Award for Excellence in Research (Healthy People) (2017), and the UTS Research Excellence Through Partnership award (2013). Her PhD was on “Pharmaceutical Policy in Australia: Developing Methods to Manage Uncertainty in Health Technology Assessment”, for which she received the UTS Chancellor’s List award in 2016.

She was a member of the Ezetimibe Review Reference Group for the Australian Government Department of Health (2016-2017), and is currently a member of the NSW Cancer Council’s Pathways Scientific Advisory Committee on Colorectal Cancer and Lynch Syndrome (2018 -) and the Australian Clinical Trials Alliance Health Economics Alongside Trials Special Interest Group (ACTA HEAT SIG). She is currently on the editorial board of Pharmacoeconomics, and is an associate editor of Oxford Open Economics.

Bonny has excellent skills in presenting complex economic research in ways that captivates an audience’s attention and is understandable. She taught health economics as part of the Masters of Public Health (2017-2023), regularly teaches short courses on economic evaluation, and is reguarly interviewed in the media regarding pharmaceutical policy in Australia.